Abstract
Aging is a progressive accumulation of changes with time that are associated with loss of physiological integrity and impaired functions, responsible for ever-increasing susceptibility to diseases and vulnerability to death. It is one of the strongest risk factors for diseases due to decline in regenerative capacity. This regenerative failure has been linked to decline in systemic factors and elevation of pro-inflammatory cytokines that impede stem cell function and stem cell niche. Recently, heterochronic parabiosis involving surgical attachment of young and old animals sharing common vasculature has revealed that systemic environment has a profound effect on stem cell function and may restore regeneration process and even reverse human tissue aging. Circulatory growth factors from young animals have been shown to reverse age-related cardiac hypertrophy, increase neurogenesis and synapses, rejuvenate and re-modulate skin tissue and rejuvenate stem cell niche revealing a new therapeutic opportunity for aging and age-related diseases in humans.
Abbreviations
- ASES:
-
American Shoulder and Elbow Surgeons score
- CTRI:
-
Clinical Trials Registry of India
- DFU:
-
Diabetes foot ulcer
- GFC:
-
Growth factor concentrate
- MSC:
-
Mesenchymal stem cells
- PRTEE:
-
Patient-rated tennis elbow evaluation
- RAWM:
-
Radial arm water maze
- VAS:
-
Visual analogue score
References
United Nation, Department of Economic and Social Welfare, Population Division. World Population Aging 2013, ST/ESA/SER, A/348; 2013.
Lopez-Otin C, Blasco MA, Partridge L, et al. The hallmark of aging. Cell. 2013;153:1194–217.
Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120:437–47.
Jones DL, Rando TA. Emerging models and paradigms for stem cell ageing. Nat Cell Biol. 2011;13:506–12.
Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nat Rev Neurosci. 2006;7:30–40.
Sharpless NE, DePinho RA. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol. 2007;8:703–13.
Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, et al. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease. Brain. 2016;139(Pt 3):922–36. doi:10.1093/brain/awv404.
Lavasani M, Robinson AR, Lu A, et al. Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun. 2012;3:608. doi:10.1038/ncomms1611.
Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–4.
Villeda SA, Luo J, Mosher KI, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90–4.
Heissig B, Ohki Y, Sato Y, et al. A role for niches in hematopoietic cell development. Hematology. 2005;10(3):247–53.
Nekanti U, Mohanty L, Venugopal P, et al. Optimization and scale-up of Wharton’s jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res. 2010;5:244–54.
Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2009;3:163–74.
Govindasamy V, Ronald VS, Totey S, et al. Micromanipulation of culture niche permits long-term expansion of dental pulp stem cells—an economic and commercial angle. In Vitro Cell Dev Biol Anim. 2010;46:764–73.
Liu L, Rando TA. Manifestations and mechanisms of stem cell aging. J Cell Biol. 2011;193:257–66.
da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008;26:2287–99.
da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–13.
Oh J, Lee YD, Wagers AJ. Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med. 2014;20:870–80.
DeCarolis NA, Kirby ED, Wyss-Coray T, et al. The role of the microenvironmental niche in declining stem-cell functions associated with biological aging. Cold Spring Harb Perspect Med. 2015;5. pii:a025874. doi:10.1101/cshperspect.a025874.
Conboy IM, Rando TA. Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Cell Cycle. 2012;11:2260–7.
van der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2009;71:241–60. doi:10.1146/annurev.physiol.010908.163145.
Zhou Z, Akinbiyi T, Xu L, et al. Tendon derived stem/progenitor cell aging: defective self-renewal and altered fate. Aging Cell. 2010;9:911–5. doi:10.1111/j.1474-9726.2010.00598.x.
Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829–48. doi:10.3727/096368915X689622. Epub 2015 Sep 29.
Nowbar AN, Mielewczik M, Karavassilis M, et al. Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ. 2014;348:g2688. doi:10.1136/bmj.g2688.
Abbott A. Doubts over heart stem cell therapy. Nature. 2014;509:15–6.
Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007;317:807–10. PMID:17690295. http://dx.doi.org/10.1126/science.1144090.
Sinha M, Jang YC, Oh J, Khong D, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014;344(6184):649–52.
Katsimpardi L, Litterman NK, Schein PA, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science. 2014;344:630–4.
Villeda SA, Plambeck KE, Middeldorp J, et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med. 2014;20(6):659–63.
Shurin GV, Yurkovetsky ZR, Chatta GS, et al. Dynamic alteration of soluble serum biomarkers in healthy aging. Cytokine. 2007;39:123–9.
Toledano H, D’Alterio C, Czech B, et al. The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche. Nature. 2012;485(7400):605–10.
Olson KA, Beatty AL, Heidecker B, et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts. Eur Heart J. 2015;36(48):3426–34.
Bitto A, Kaeberlein M. Rejuvenation: it’s in our blood. Cell Metab. 2014;20(1):2–4.
Di Mitri D, Azevedo RI, Henson SM, et al. Reversible senescence in human CD4+CD45RA+ CD27- memory T cells. J Immunol. 2011;187:2093–100.
Lapasset L, Milhavet O, Prieur A, et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011;25:2248–53.
Han J, Mistriotis P, Lei P, et al. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells. 2012;30:2746–59.
Mason JB, Cargill SL, Anderson GB, et al. Transplantation of young ovaries to old mice increased life span in transplant recipients. J Gerontol A Biol Sci Med Sci. 2009;64:1207–11.
Carlson BM, Faulkner JA. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol. 1989;256:1262–6. PMID:2735398.
Conboy MJ, Conboy IM, Rando TA. Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell. 2013;12(3):525–30.
Eggel A, Coray TW. Parabiosis for the study of age related chronic diseases. Swiss Med Wkly. 2014;144:w13914. doi:10.4414/smw.2014.13914.
Sherwood RI, Christensen JL, Weissman IL, et al. Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells. 2004;22(7):1292–304.
McCay CM, Pope F, Lunsford W, et al. Parabiosis between old and young rats. Gerontologia. 1957;1:7–17.
Ludwig FC, Elashoff RM. Mortality in syngeneic rat parabionts of different chronological age. Trans N Y Acad Sci. 1972;34(7):582–7.
Blau HM, Cosgrove BD, Ho AT. The central role of muscle stem cells in regenerative failure with aging. Nat Med. 2015;21:854–62.
Ding HY, Ma HX. Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease. J Geriatr Cardiol. 2015;12(4):439–47.
Dai S, Zhang S, Guo Y, et al. C-reactive protein and atrial fibrillation in idiopathic dilated cardiomyopathy. Clin Cardiol. 2009;32(9):E45–50.
Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013;153(4):828–39.
McPherron AC. Through thick and thin: a circulating growth factor inhibits age-related cardiac hypertrophy. Circ Res. 2013;113(5):487–91.
Harper SC, Brack A, MacDonnell S, et al. Is growth differentiation factor 11 a realistic therapeutic for aging-dependent muscle defects. Circ Res. 2016;118:1143–50.
Salpeter SJ, Khalaileh A, Weinberg-Corem N, et al. Systemic regulation of the age-related decline of pancreatic β-cell replication. Diabetes. 2013;62(8):2843–8.
Baht GS, Silkstone D, Vi L, et al. Exposure to a youthful circulation rejuvenates bone repair through modulation of β-catenin. Nat Commun. 2015;6:7131. doi:10.1038/ncomms8131.
Sevilla GP, Dhurat RS, Shetty G, et al. Safety and efficacy of growth factor concentrate in the treatment of nasolabial fold correction: split face pilot study. Indian J Dermatol. 2015;60(5):520. doi:10.4103/0019-5154.159628.
Acknowledgements
The author is thankful to the management of Kasiak Research and Aureostem Research for providing generous support. Their generosity was instrumental for the study accomplishment, and I appreciate it. The author is thankful to Dr. Gema Sevilla, Instituto Medico Laser, Madrid Spain; Dr. Rachita Dhurat, Lokmanya Tilak Municipal Medical College and Hospital, Sion, Mumbai, India; and Dr. Geetanjali Shetty, Goregaon, Mumbai, India, for participating in the clinical studies. The author also thanks IITB-Monash Research Academy; Indian Institute of Technology (IIT), Mumbai; and Invitrogen BioServices, Bangalore, India, for the analysis of blood-derived signalling factors. The author thanks all the supporting staff and technicians for the technical and scientific support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Totey, S. (2017). Blood to Blood: A New Therapeutic Opportunity for Age-Related Diseases. In: Mukhopadhyay, A. (eds) Regenerative Medicine: Laboratory to Clinic. Springer, Singapore. https://doi.org/10.1007/978-981-10-3701-6_26
Download citation
DOI: https://doi.org/10.1007/978-981-10-3701-6_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3700-9
Online ISBN: 978-981-10-3701-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)